Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Genentech Offers 10 Years of Refunds on High-Selling Drug, Multi-Year on Another; Merck to Give Single-Quarter Refunds
Rich Daly Editor in Chief
Views
Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
